Cargando…

Risk of second cancer in esophageal squamous cell carcinoma and adenocarcinoma survivors: a population-based analysis in SEER dataset

BACKGROUND: Previous studies have reported increased risk of second cancer in both esophageal squamous cell cancer (ESCC) and esophageal adenocarcinoma (EAC) survivors. This study aimed to examine the risk and influential factors of second cancer in ESCC and EAC patients. METHODS: This population-ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Xiaona, Su, Xiaoying, Wang, Changhong, Yao, Qiang, Fan, Yuying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643214/ https://www.ncbi.nlm.nih.gov/pubmed/38021360 http://dx.doi.org/10.21037/tgh-23-29

Ejemplares similares

Second primary malignancy in patients with esophageal adenocarcinoma and squamous cell carcinoma
por: Zhang, Guoqing, et al.
Publicado: (2019)

Better Prognosis and Survival in Esophageal Cancer Survivors After Comorbid Second Primary Malignancies: A SEER Database-Based Study
por: Ye, Jiayue, et al.
Publicado: (2022)

Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
por: Yasar, Hatime A
Publicado: (2023)

Survival and prognostic factors of patients with esophageal fistula in advanced esophageal squamous cell carcinoma
por: Guan, Xin, et al.
Publicado: (2020)

Better survival and prognosis in SCLC survivors after combined second primary malignancies: A SEER database-based study
por: Wang, Silin, et al.
Publicado: (2023)

Correlation between tumor location and survival in stage I lung adenocarcinoma and squamous cell carcinoma: a SEER-based study
por: Hu, Junjie, et al.
Publicado: (2021)

Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma
por: Li, Xianfeng, et al.
Publicado: (2023)

Survival outcomes for patients with four treatments in stages I–III esophageal squamous cell carcinoma: a SEER analysis
por: Wu, Jingyang, et al.
Publicado: (2021)

Survival analysis of patients with subglottic squamous cell carcinoma based on the SEER database
por: Yang, Fan, et al.
Publicado: (2021)

Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2018)

Simultaneous Esophageal Squamous Cell Carcinoma and Adenocarcinoma: A Case Report
por: Maleki, Iradj, et al.
Publicado: (2015)

Mitochondrial DNA deletions in patients with esophagitis, Barrett's esophagus, esophageal adenocarcinoma and squamous cell carcinoma
por: Keles, Muzaffer, et al.
Publicado: (2019)

Prognostic factors for squamous cervical carcinoma identified by competing-risks analysis: A study based on the SEER database
por: Hu, Chengfeng, et al.
Publicado: (2022)

Second Primary Malignancy in Patients with Hypopharyngeal Carcinoma: A SEER-Based Study
por: Guo, Liqing, et al.
Publicado: (2021)

A comparative Analysis by SAGE of Gene Expression Profiles of Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma
por: van Baal, Jantine W. P. M., et al.
Publicado: (2008)

Trends in Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma Incidence in the United States from 1992 to 2019
por: Liu, Kyle S., et al.
Publicado: (2022)

Epidemiology, Treatment, and Outcome of Pancreatic Squamous Cell Carcinoma and Pancreatic Adenocarcinoma: A Propensity Score-Matching Analysis Based on SEER-Database
por: Wang, Yuqing, et al.
Publicado: (2022)

Genetic polymorphisms of NAMPT related with susceptibility to esophageal Squamous cell carcinoma
por: Zhang, Chuanzhen, et al.
Publicado: (2015)

Gene Expression in Barrett’s Esophagus Cell Lines Resemble Esophageal Squamous Cell Carcinoma Instead of Esophageal Adenocarcinoma
por: Panda, Anshuman, et al.
Publicado: (2021)

The exploration of disease-specific gene regulatory networks in esophageal carcinoma and stomach adenocarcinoma
por: Qin, Guimin, et al.
Publicado: (2019)

Cost-effectiveness analysis of camrelizumab in the second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China
por: Yang, Fan, et al.
Publicado: (2021)

Identification of key genes and pathways for esophageal squamous cell carcinoma by bioinformatics analysis
por: Chen, Xiaohua, et al.
Publicado: (2018)

Overview of the SEER—Medicare Health Outcomes Survey Linked Dataset
por: Ambs, Anita, et al.
Publicado: (2008)

DNAJB6 Promotes Ferroptosis in Esophageal Squamous Cell Carcinoma
por: Jiang, Bin, et al.
Publicado: (2019)

Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma
por: Choy, Bonnie, et al.
Publicado: (2012)

Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
por: Li, Yan, et al.
Publicado: (2022)

Elucidating the clonal relationship of esophageal second primary tumors in patients with laryngeal squamous cell carcinoma
por: Wan, Meixuan, et al.
Publicado: (2023)

A modified survival model for patients with esophageal squamous cell carcinoma based on lymph nodes: A study based on SEER database and external validation
por: Yang, Tianbao, et al.
Publicado: (2022)

Esophageal Carcinoma with Triplicate Differentiation into Squamous Cell Carcinoma, Small Cell Carcinoma and Adenocarcinoma: a Case Report
por: Terada, Tadashi
Publicado: (2009)

Economic evaluation of tislelizumab versus chemotherapy as second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China
por: Shi, Fenghao, et al.
Publicado: (2022)

Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma
por: Yao, Jiannan, et al.
Publicado: (2021)

Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma in Patients with Squamous Cell Carcinomas of the Head and Neck?
por: Komínek, Pavel, et al.
Publicado: (2013)

Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma
por: Huai, Qilin, et al.
Publicado: (2021)

Single-cell mapping of N6-methyladenosine in esophageal squamous cell carcinoma and exploration of the risk model for immune infiltration
por: Nie, Yuanliu, et al.
Publicado: (2023)

Analysis of Differentially Expressed Genes in a Chinese Cohort of Esophageal Squamous Cell Carcinoma
por: Liu, Gang, et al.
Publicado: (2020)

A survival comparison of gastric mucin-producing adenocarcinoma to conventional adenocarcinoma: a SEER database analysis
por: Wang, Qiang, et al.
Publicado: (2021)

HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma
por: HUANG, JUN-XING, et al.
Publicado: (2013)

Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry
por: Zhang, Su, et al.
Publicado: (2020)

Advanced Esophageal Squamous Cell Dysplasia and Early Carcinoma Detected After Remote Esophagectomy for Adenocarcinoma
por: Shafa, Shervin, et al.
Publicado: (2015)

Identification of Candidate Therapeutic Genes for More Precise Treatment of Esophageal Squamous Cell Carcinoma and Adenocarcinoma
por: Polewko-Klim, Aneta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0elru1sun7uf1r4r7b2agksale